News
ANIX
3.070
+1.99%
0.060
Weekly Report: what happened at ANIX last week (0415-0419)?
Weekly Report · 2d ago
ANIXA BIOSCIENCES WELCOMES CELEBRITY ONCOLOGIST DR. SANJAY JUNEJA TO ITS CANCER BUSINESS ADVISORY BOARD
Reuters · 6d ago
Press Release: Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Dr. Juneja is a board-certified hematologist and medical oncologist.
Dow Jones · 6d ago
Weekly Report: what happened at ANIX last week (0408-0412)?
Weekly Report · 04/15 10:10
Weekly Report: what happened at ANIX last week (0401-0405)?
Weekly Report · 04/08 10:13
Weekly Report: what happened at ANIX last week (0325-0329)?
Weekly Report · 04/01 10:12
Weekly Report: what happened at ANIX last week (0318-0322)?
Weekly Report · 03/25 10:14
Anixa Biosciences Stockholders Affirm Confidence and Oversight
TipRanks · 03/22 20:42
Anixa Biosciences Price Target Maintained With a $12.00/Share by HC Wainwright & Co.
Dow Jones · 03/21 10:43
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
Benzinga · 03/21 10:33
Anixa Biosciences: A Buy Rating on Strong Financials and Promising Oncology Advances
TipRanks · 03/21 10:17
Weekly Report: what happened at ANIX last week (0311-0315)?
Weekly Report · 03/18 10:13
Recap: Anixa Biosciences Q1 Earnings
Anixa Biosciences reported its Q1 earnings on March 12. The company missed estimates by -11.0% and missed revenue by $0.1. Anixa will report its earnings on Tuesday, March 12 at 5:00 p.m.
Benzinga · 03/12 21:45
Weekly Report: what happened at ANIX last week (0304-0308)?
Weekly Report · 03/11 10:11
Weekly Report: what happened at ANIX last week (0226-0301)?
Weekly Report · 03/04 10:13
Weekly Report: what happened at ANIX last week (0219-0223)?
Weekly Report · 02/26 10:20
Weekly Report: what happened at ANIX last week (0212-0216)?
Weekly Report · 02/19 10:20
Anixa Biosciences Price Target Maintained With a $12.00/Share by HC Wainwright & Co.
Dow Jones · 02/13 17:37
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
Benzinga · 02/13 17:28
Analysts Conflicted on These Healthcare Names: Anixa Biosciences (ANIX) and InMode (INMD)
TipRanks · 02/13 17:20
More
Webull provides a variety of real-time ANIX stock news. You can receive the latest news about Anixa Biosciences Inc through multiple platforms. This information may help you make smarter investment decisions.
About ANIX
Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs include the development of a preventative vaccine against triple negative breast cancer (TNBC), the most lethal form of breast cancer, as well as other forms of breast cancer and the development of a preventative vaccine against ovarian cancer. Its therapeutics programs include the development of a chimeric endocrine receptor T cell therapy, a novel form of chimeric antigen receptor T cell (CAR-T) technology, initially focused on treating ovarian cancer, which is being developed by its subsidiary, Certainty Therapeutics, Inc. (Certainty). Certainty is developing immuno-therapy drugs against cancer. The Company’s vaccine portfolio consists of technology focused on the immunization against specific retired proteins.